Cencora (COR): Copeland Capital Management, LLC added to its stake +55K shares
Copeland Capital Management, LLC added to its stake in Cencora, per its Q1 2025 13F.
- 55K
- Shares reported · +55K vs prior quarter
- 0.31%
- Disclosed portfolio weight
- $15.4M
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- Apr 24, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 21, 2025InsiderOfficer sold ~$1.21M of COR shares in the open market
- Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$3.7M)
- Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
- Mar 10, 2025InsiderOfficer sold ~$520K of COR shares in the open market
- Mar 18, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
- Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
- Mar 24, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
- Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
- Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
- Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
- Apr 21, 2025InsiderCEO sold ~$1.44M of COR shares in the open market
- Apr 22, 2025InsiderChair sold ~$4.11M of COR shares in the open market
What came next
- May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
- May 14, 2025InsiderDirector sold ~$837K of COR shares in the open market
- May 15, 2025FDARecall: Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus…
- May 19, 2025InsiderCEO sold ~$1.45M of COR shares in the open market
- May 20, 2025InsiderChair sold ~$4.28M of COR shares in the open market
- May 29, 2025Insider · 1 personInsiders: 2 sales (~$867K)
- Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
- Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
- Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
- Jul 22, 2025InsiderChair sold ~$4.27M of COR shares in the open market
- Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…
- Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
- Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Cencora
For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.
How this filing works
Explore the data
Common questions
What does this filing report about Cencora (COR) stock?
Copeland Capital Management, LLC added to its stake in Cencora, per its Q1 2025 13F. Now 55K shares, $15.4M reported value, 0.31% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: Apr 24, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cencora recently?
For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.
Does this mean COR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cencora
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Oct 5, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 144Sep 16, 2026
- SEC Form 144Sep 11, 2026
Everything OQRO holds on this company is on its COR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
